[144] Tenet Healthcare Corporation New SEC Filing
Tenet Healthcare (THC) Form 144 summary: An insider filed a notice to sell 8,000 common shares through Fidelity Brokerage Services on or about 08/20/2025. The filing lists an aggregate market value of $1,436,278.72 and total shares outstanding of 88,351,000, meaning the proposed sale equals approximately 0.0091% of outstanding shares. All 8,000 shares were acquired by restricted stock vesting from the issuer as compensation on dates in 2023 and 2024 (658; 1,088; 3,946; 2,308). The filer reports no securities sold in the past three months and makes the required representation about lack of undisclosed material information.
Riepilogo del Form 144 di Tenet Healthcare (THC): Un insider ha presentato una segnalazione per vendere 8.000 azioni ordinarie tramite Fidelity Brokerage Services in data approssimativa 20/08/2025. La comunicazione indica un valore di mercato aggregato di $1.436.278,72 e un totale di azioni in circolazione pari a 88.351.000, il che significa che la vendita proposta corrisponde a circa il 0,0091% delle azioni in circolazione. Tutte le 8.000 azioni sono state acquisite come vesting di azioni soggette a restrizioni dall'emittente come compenso in date del 2023 e 2024 (658; 1.088; 3.946; 2.308). Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e fornisce la dichiarazione richiesta sulla mancanza di informazioni materiali non divulgate.
Resumen del Formulario 144 de Tenet Healthcare (THC): Un insider presentó un aviso para vender 8.000 acciones ordinarias a través de Fidelity Brokerage Services aproximadamente el 20/08/2025. La presentación cifra un valor de mercado agregado de $1.436.278,72 y un total de acciones en circulación de 88.351.000, lo que significa que la venta propuesta equivale aproximadamente al 0,0091% de las acciones en circulación. Las 8.000 acciones fueron adquiridas como acciones restringidas que han ido adquiriéndose (vesting) del emisor como compensación en fechas de 2023 y 2024 (658; 1.088; 3.946; 2.308). El declarante informa que no ha vendido valores en los últimos tres meses y realiza la declaración requerida sobre la falta de información material no divulgada.
테넷 헬스케�(THC) Form 144 요약: 내부자가 Fidelity Brokerage Services� 통해 � 2025-08-20경에 보통� 8,000주를 매각한다� 신고� 제출했습니다. 보고서에� � 시가총액 $1,436,278.72와 발행주식 총수 88,351,000�가 기재되어 있어 제안� 매각 규모� 전체 주식� � 0.0091%� 해당합니�. 해당 8,000� 전부� 발행사가 보상으로 부여한 제한부 주식� 베스�(가� 취득)으로 2023� � 2024년에 취득� 주식들입니다(658; 1,088; 3,946; 2,308). 제출자는 과거 3개월 동안 매도� 증권� 없다� 보고하고, 미공� 중요 정보가 없다� 필요� 진술� 합니�.
Résumé du Formulaire 144 de Tenet Healthcare (THC) : Un initié a déposé un avis pour vendre 8 000 actions ordinaires via Fidelity Brokerage Services aux alentours du 20/08/2025. Le dépôt indique une valeur de marché globale de 1 436 278,72 $ et un total d'actions en circulation de 88 351 000, ce qui signifie que la vente proposée représente environ 0,0091 % des actions en circulation. Les 8 000 actions ont toutes été acquises par vesting d'actions restreintes de l'émetteur en tant que rémunération aux dates de 2023 et 2024 (658 ; 1 088 ; 3 946 ; 2 308). Le déclarant signale aucune vente de titres au cours des trois derniers mois et fait la déclaration requise concernant l'absence d'informations matérielles non divulguées.
Zusammenfassung des Form 144 von Tenet Healthcare (THC): Ein Insider hat eine Mitteilung eingereicht, um etwa am 20.08.2025 8.000 Stammaktien über Fidelity Brokerage Services zu verkaufen. Die Einreichung nennt einen aggregierten Marktwert von $1.436.278,72 und insgesamt 88.351.000 ausstehende Aktien, was bedeutet, dass der vorgeschlagene Verkauf ungefähr 0,0091% der ausstehenden Aktien entspricht. Alle 8.000 Aktien wurden durch Vesting eingeschränkter Aktien vom Emittenten als Vergütung in den Jahren 2023 und 2024 erworben (658; 1.088; 3.946; 2.308). Der Einreicher berichtet, in den letzten drei Monaten keine Wertpapiere verkauft zu haben und gibt die erforderliche Erklärung ab, dass keine nicht offengelegten wesentlichen Informationen vorliegen.
- Full disclosure of broker and proposed sale details including broker name, share count, aggregate market value, and approximate sale date
- Acquisition details provided showing all 8,000 shares were acquired via restricted stock vesting as compensation with specific dates and amounts
- No securities sold in prior three months reported, simplifying aggregation calculations under Rule 144
- None.
Insights
TL;DR: Insider plans a small sale of vested compensation shares; not material to market capitalization.
The filer intends to sell 8,000 common shares valued at $1.44 million through Fidelity on or about 08/20/2025. These shares were granted and vested as compensation across 2023 and 2024, indicating the transaction is a monetization of compensation rather than an open-market stake disposal. The sale represents roughly 0.0091% of the company's 88.35 million outstanding shares, a de minimis amount unlikely to affect liquidity or share price materially.
TL;DR: Filing appears procedurally compliant and includes required vesting and acquisition details.
The Form 144 provides required broker, share count, aggregate value, acquisition dates, and nature of acquisition (restricted stock vesting). It also states no sales in the prior three months and includes the standard attestation regarding material nonpublic information. There is no indication in the filing of a 10b5-1 plan adoption date or other trading-plan specifics, and no adverse events or disclaimers beyond the standard notices are provided.
Riepilogo del Form 144 di Tenet Healthcare (THC): Un insider ha presentato una segnalazione per vendere 8.000 azioni ordinarie tramite Fidelity Brokerage Services in data approssimativa 20/08/2025. La comunicazione indica un valore di mercato aggregato di $1.436.278,72 e un totale di azioni in circolazione pari a 88.351.000, il che significa che la vendita proposta corrisponde a circa il 0,0091% delle azioni in circolazione. Tutte le 8.000 azioni sono state acquisite come vesting di azioni soggette a restrizioni dall'emittente come compenso in date del 2023 e 2024 (658; 1.088; 3.946; 2.308). Il dichiarante segnala di non aver venduto titoli negli ultimi tre mesi e fornisce la dichiarazione richiesta sulla mancanza di informazioni materiali non divulgate.
Resumen del Formulario 144 de Tenet Healthcare (THC): Un insider presentó un aviso para vender 8.000 acciones ordinarias a través de Fidelity Brokerage Services aproximadamente el 20/08/2025. La presentación cifra un valor de mercado agregado de $1.436.278,72 y un total de acciones en circulación de 88.351.000, lo que significa que la venta propuesta equivale aproximadamente al 0,0091% de las acciones en circulación. Las 8.000 acciones fueron adquiridas como acciones restringidas que han ido adquiriéndose (vesting) del emisor como compensación en fechas de 2023 y 2024 (658; 1.088; 3.946; 2.308). El declarante informa que no ha vendido valores en los últimos tres meses y realiza la declaración requerida sobre la falta de información material no divulgada.
테넷 헬스케�(THC) Form 144 요약: 내부자가 Fidelity Brokerage Services� 통해 � 2025-08-20경에 보통� 8,000주를 매각한다� 신고� 제출했습니다. 보고서에� � 시가총액 $1,436,278.72와 발행주식 총수 88,351,000�가 기재되어 있어 제안� 매각 규모� 전체 주식� � 0.0091%� 해당합니�. 해당 8,000� 전부� 발행사가 보상으로 부여한 제한부 주식� 베스�(가� 취득)으로 2023� � 2024년에 취득� 주식들입니다(658; 1,088; 3,946; 2,308). 제출자는 과거 3개월 동안 매도� 증권� 없다� 보고하고, 미공� 중요 정보가 없다� 필요� 진술� 합니�.
Résumé du Formulaire 144 de Tenet Healthcare (THC) : Un initié a déposé un avis pour vendre 8 000 actions ordinaires via Fidelity Brokerage Services aux alentours du 20/08/2025. Le dépôt indique une valeur de marché globale de 1 436 278,72 $ et un total d'actions en circulation de 88 351 000, ce qui signifie que la vente proposée représente environ 0,0091 % des actions en circulation. Les 8 000 actions ont toutes été acquises par vesting d'actions restreintes de l'émetteur en tant que rémunération aux dates de 2023 et 2024 (658 ; 1 088 ; 3 946 ; 2 308). Le déclarant signale aucune vente de titres au cours des trois derniers mois et fait la déclaration requise concernant l'absence d'informations matérielles non divulguées.
Zusammenfassung des Form 144 von Tenet Healthcare (THC): Ein Insider hat eine Mitteilung eingereicht, um etwa am 20.08.2025 8.000 Stammaktien über Fidelity Brokerage Services zu verkaufen. Die Einreichung nennt einen aggregierten Marktwert von $1.436.278,72 und insgesamt 88.351.000 ausstehende Aktien, was bedeutet, dass der vorgeschlagene Verkauf ungefähr 0,0091% der ausstehenden Aktien entspricht. Alle 8.000 Aktien wurden durch Vesting eingeschränkter Aktien vom Emittenten als Vergütung in den Jahren 2023 und 2024 erworben (658; 1.088; 3.946; 2.308). Der Einreicher berichtet, in den letzten drei Monaten keine Wertpapiere verkauft zu haben und gibt die erforderliche Erklärung ab, dass keine nicht offengelegten wesentlichen Informationen vorliegen.